Ming Jiang
Impact in
-
- Lymphoma Diagnosis and Treatment
- Oncology top 10%
- Viral-associated cancers and disorders
Papers in
- Oncology 21
- Viral-associated cancers and disorders 7
- Cancer Cells and Metastasis 3
-
- Lymphoma Diagnosis and Treatment 15
- Co-authors
- Dan Cao (6 shared papers)Hongfeng Gou (4 shared papers)Liqun Zou (19 shared papers)Mei Hou (4 shared papers)Yong‐Song Guan (3 shared papers)Yang Yu (1 shared paper)Yu Jiang (7 shared papers)Xi Yan (4 shared papers)
- Journals
- Medical Oncology (3 papers)Blood (2 papers)Oncotarget (2 papers)Frontiers in Oncology (2 papers)Journal of Clinical Oncology (2 papers)
- Partner nations
- ChinaUnited StatesHungary
In The Last Decade
Ming Jiang
58 papers receiving 1.2k citations
Ming Jiang's Hit Papers
Peers
Comparison fields: 5 of 99
- Pathology and Forensic Medicine 338
- Oncology 320
- Hematology 127
- Cancer Research 151
- Immunology 185
Countries citing papers authored by Ming Jiang
This map shows the geographic impact of Ming Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Jiang more than expected).
Fields of papers citing papers by Ming Jiang
This network shows the impact of papers produced by Ming Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Jiang. The network helps show where Ming Jiang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ming Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 185 | |
| 2 | 2011 | 104 | |
| 3 | 2009 | 83 | |
| 4 | 2016 | 82 | |
| 5 | 2010 | 65 | |
| 6 | Consensus on the monitoring, treatment, and prevention of leukaemia relapse after allogeneic haematopoietic stem cell transplantation in China: 2024 update Hit paper breakdown → | 2024 | 56 |
| 7 | 2010 | 48 | |
| 8 | 2015 | 38 | |
| 9 | 2024 | 34 | |
| 10 | 2020 | 33 | |
| 11 | 2015 | 32 | |
| 12 | 2015 | 24 | |
| 13 | 2010 | 23 | |
| 14 | 2013 | 23 | |
| 15 | 2017 | 22 | |
| 16 | 2015 | 21 | |
| 17 | 2012 | 18 | |
| 18 | 2023 | 18 | |
| 19 | 2024 | 18 | |
| 20 | 2018 | 15 |
About Ming Jiang
Ming Jiang is a scholar working on Oncology, Pathology and Forensic Medicine, Immunology, Cancer Research and Molecular Biology, having authored 65 papers that have together received 1.2k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (15 papers), Viral-associated cancers and disorders (7 papers), Hematopoietic Stem Cell Transplantation (3 papers), Cancer Cells and Metastasis (3 papers), CNS Lymphoma Diagnosis and Treatment (3 papers), Immune cells in cancer (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Maternal Mental Health During Pregnancy and Postpartum (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (338 citations), Oncology (320 citations), Hematology (127 citations), Cancer Research (151 citations) and Immunology (185 citations). Ming Jiang has collaborated with scholars based in China, United States and Hungary. Frequent co-authors include Dan Cao, Hongfeng Gou, Liqun Zou, Mei Hou, Yong‐Song Guan, Yang Yu, Yu Jiang, Xi Yan, Yu Yang and Feng Luo. Their work appears in journals such as Medical Oncology, Blood, Oncotarget, Frontiers in Oncology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.